DEPOSITS OF EOSINOPHIL GRANULE PROTEINS IN CARDIAC TISSUES OF PATIENTS WITH EOSINOPHILIC ENDOMYOCARDIAL DISEASE

[1]  P. Venge,et al.  Mechanism of membrane damage mediated by human eosinophil cationic protein , 1986, Nature.

[2]  F. Villalta,et al.  Role of inflammatory cells in Chagas' disease. III. Kinetics of human eosinophil activation upon interaction with parasites (Trypanosoma cruzi). , 1986, Journal of immunology.

[3]  H. Sampson,et al.  Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. , 1985, The New England journal of medicine.

[4]  D. Catovsky,et al.  Hypereosinophilic syndrome preceding T cell lymphoblastic lymphoma. , 1985, Clinical and laboratory haematology.

[5]  E. Olsen,et al.  Relation between eosinophilia and endomyocardial disease. , 1985, Progress in cardiovascular diseases.

[6]  A. Gibbs,et al.  Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. , 1984, British medical journal.

[7]  W. Edwards,et al.  Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsy. , 1984, The American journal of cardiology.

[8]  I. Olsson,et al.  Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein , 1984, Nature.

[9]  J. Harley,et al.  Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. , 1983, Journal of immunology.

[10]  E. Zanjani,et al.  Pulmonary carcinoma with eosinophilia. Demonstration of a tumor-derived eosinophilopoietic factor. , 1983, The New England journal of medicine.

[11]  P. Venge,et al.  Purification and characterization of a new cationic protein--eosinophil protein-X (EPX)--from granules of human eosinophils. , 1983, Immunology.

[12]  A. Butterworth,et al.  Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro , 1983, The Journal of experimental medicine.

[13]  C. Oakley,et al.  Clinical features of fifteen patients with the hypereosinophilic syndrome. , 1983, The Quarterly journal of medicine.

[14]  I. Olsson,et al.  Altered density, metabolism and surface receptors of eosinophils in eosinophilia. , 1982, Immunology.

[15]  K. E. Holley,et al.  IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMA , 1982, The Lancet.

[16]  D. J. Hayes,et al.  Toxic effects of human eosinophil products on isolated rat heart cells in vitro. , 1982, The Biochemical journal.

[17]  P. Greipp,et al.  Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome. , 1982, JAMA.

[18]  G. Gleich,et al.  An immunofluorescent method for specific staining of eosinophil granule major basic protein. , 1981, Journal of immunological methods.

[19]  R. Schooley,et al.  Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. , 1981, The Journal of clinical investigation.

[20]  D. Loegering,et al.  Cytotoxic properties of the eosinophil major basic protein. , 1979, Journal of immunology.

[21]  W. Henry,et al.  The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. , 1979, The American journal of medicine.

[22]  I. Olsson,et al.  Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. , 1977, Laboratory investigation; a journal of technical methods and pathology.

[23]  G. Solley,et al.  Endomyocardiopathy with eosinophilia. , 1976, Mayo Clinic proceedings.

[24]  I. Brockington,et al.  Löffler's endocarditis and Davies' endomyocardial fibrosis , 1973 .